Comparative effectiveness and safety of non‐tumour necrosis factor biologics and Janus kinase inhibitors in patients with active rheumatoid arthritis showing insufficient response to tumour necrosis factor inhibitors: A Bayesian network meta‐analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Comparative effectiveness and safety of non‐tumour necrosis factor biologics and Janus kinase inhibitors in patients with active rheumatoid arthritis showing insufficient response to tumour necrosis factor inhibitors: A Bayesian network meta‐analysis of randomized controlled trials

Published:2021-02-18 Issue:4 Volume:46 Page:984-992
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Sung Yoon‐Kyoung¹,Lee Young Ho²^ORCID

Affiliation:

1. Department of Rheumatology Hanyang University Hospital for Rheumatic Diseases Seoul Korea

2. Department of Rheumatology Korea University College of Medicine Seoul Korea

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13380

Reference47 articles.

1. Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

2. Janus kinases in immune cell signaling

3. Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled tri

4. Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in active rheumatoid arthritis refractory to biologic disease‐modifying antirheumatic drugs;Lee YH;Z Rheumatol,2020

5. Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas y sintéticas dirigidas en la artritis reumatoide;Reumatología Clínica;2024-07

2. Actualización de las Guías para el Tratamiento Farmacológico de la Artritis Reumatoide del Colegio Mexicano de Reumatología 2023;Reumatología Clínica;2024-05

3. Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023;Reumatología Clínica (English Edition);2024-05

4. Clinical Outcomes in Patients with Rheumatoid Arthritis After Switching Between Interleukin-6-Receptor Inhibitors and Janus Kinase Inhibitors: Findings from an Observational Study;Rheumatology and Therapy;2023-10-31

5. Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis;Rheumatology and Therapy;2023-09-16